학술논문
Efficacy and safety of tirzepatide monotherapy compared with dulaglutide in Japanese patients with type 2 diabetes (SURPASS J-mono): a double-blind, multicentre, randomised, phase 3 trial
Document Type
Article
Source
In The Lancet Diabetes & Endocrinology September 2022 10(9):623-633
Subject
Language
ISSN
2213-8587